Investigation of the relationship between these clonotypic or CD30/CD15 negative B cells and HRS cells may provide not only additional information concerning the origin of the tumor cells, but may also help to define a new therapeutic strategy targeting the cancer stem cells of HL. This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.